HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Morelli Selected Research

esmolol (Brevibloc)

1/2021Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.
12/2020Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.
11/2016Esmolol in septic shock: old pathophysiological concepts, an old drug, perhaps a new hemodynamic strategy in the right patient.
10/2013Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
9/2013Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Morelli Research Topics

Disease

44Septic Shock (Toxic Shock Syndrome)
01/2021 - 04/2004
22Sepsis (Septicemia)
01/2020 - 05/2005
17Hypotension (Low Blood Pressure)
01/2021 - 01/2005
11Shock
01/2021 - 06/2007
9Critical Illness (Critically Ill)
01/2021 - 12/2003
8Endotoxemia
05/2011 - 01/2006
5Respiratory Insufficiency (Respiratory Failure)
04/2017 - 11/2004
4Heart Failure
01/2021 - 12/2013
4Tachycardia (Tachyarrhythmias)
12/2020 - 01/2008
4Infections
12/2019 - 06/2014
4Acute Kidney Injury (Acute Renal Failure)
10/2017 - 11/2005
4Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
06/2014 - 06/2007
4Stroke (Strokes)
10/2013 - 11/2007
3Left Ventricular Dysfunction
01/2022 - 05/2005
3Low Cardiac Output
01/2021 - 11/2016
2COVID-19
09/2021 - 10/2020
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2020 - 09/2006
2Hemorrhage
01/2020 - 10/2009
2Hypertension (High Blood Pressure)
01/2019 - 01/2005
2Inflammation (Inflammations)
05/2011 - 04/2008
2Peritonitis
01/2011 - 10/2010
1Dehydration (Water Stress)
01/2022
1Hyperthermia
01/2022
1Pulmonary Embolism
01/2022
1Hypercapnia
01/2022
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Headache (Headaches)
09/2021
1Cardiogenic Shock
01/2021
1Hemorrhagic Shock
01/2020
1Lactic Acidosis
10/2018
1Atrial Fibrillation
01/2018
1Liver Failure
10/2016

Drug/Important Bio-Agent (IBA)

22CatecholaminesIBA
01/2020 - 04/2004
21Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021 - 04/2004
16TerlipressinIBA
01/2018 - 04/2004
14Simendan (Levosimendan)IBA
10/2017 - 05/2005
10Vasopressins (Vasopressin)IBA
01/2018 - 04/2004
10Oxygen (Dioxygen)IBA
10/2016 - 12/2003
8Saline SolutionIBA
04/2011 - 01/2006
8Arginine Vasopressin (Argipressin)IBA
01/2011 - 01/2006
7DobutamineFDA LinkGeneric
01/2021 - 09/2004
6Pharmaceutical PreparationsIBA
01/2022 - 01/2005
5esmolol (Brevibloc)FDA LinkGeneric
01/2021 - 09/2013
5Potassium Channels (Potassium Channel)IBA
01/2019 - 10/2007
5Vasoconstrictor AgentsIBA
10/2009 - 11/2007
4Adenosine Triphosphate (ATP)IBA
01/2019 - 06/2007
4Lactic Acid (Lactate)FDA LinkGeneric
10/2018 - 04/2011
4CalciumIBA
07/2014 - 05/2005
4Fenoldopam (Corlopam)FDA LinkGeneric
12/2013 - 12/2003
3KATP ChannelsIBA
01/2019 - 10/2007
3PotassiumIBA
01/2019 - 06/2007
3Anti-Bacterial Agents (Antibiotics)IBA
10/2018 - 09/2014
3CreatinineIBA
04/2011 - 04/2004
3EndotoxinsIBA
04/2011 - 11/2007
2Sodium ChlorideFDA LinkGeneric
01/2020 - 01/2018
2Starch (Cornstarch)IBA
01/2020 - 12/2013
2Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link
01/2020 - 04/2010
2Glipizide (Glucotrol)FDA LinkGeneric
01/2019 - 06/2007
2Remifentanil (Ultiva)FDA Link
01/2019 - 12/2010
2landiololIBA
11/2018 - 01/2018
2Carbon DioxideIBA
04/2017 - 01/2017
2Adrenergic Receptors (Adrenergic Receptor)IBA
10/2013 - 09/2013
2Crystalloid SolutionsIBA
04/2011 - 04/2010
2Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
10/2009 - 06/2008
2Glyburide (Glibenclamide)FDA LinkGeneric
04/2008 - 11/2007
2Phenylephrine (Neo-Synephrine)FDA LinkGeneric
04/2008 - 01/2008
1poly(N-vinylcaprolactam-co-acrylic acid)IBA
01/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1COVID-19 VaccinesIBA
09/2021
1Messenger RNA (mRNA)IBA
09/2021
1VaccinesIBA
09/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
01/2019
1Propofol (Diprivan)FDA LinkGeneric
01/2019
1Tetraethylammonium (Tetraethylammonium Bromide)IBA
01/2019
1TeaIBA
01/2019
1DexmedetomidineFDA Link
01/2019
1salicylhydroxamic acid (SHAM)IBA
10/2018
1Pyruvic Acid (Pyruvate)IBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1Glycerol (Glycerine)FDA LinkGeneric
01/2017
1Lipopolysaccharide ReceptorsIBA
03/2015

Therapy/Procedure

20Therapeutics
01/2021 - 01/2008
6Resuscitation
01/2021 - 01/2008
5Artificial Respiration (Mechanical Ventilation)
01/2022 - 06/2014
4Critical Care (Surgical Intensive Care)
01/2018 - 12/2009
3Injections
01/2018 - 11/2007
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2022 - 11/2004
2Extracorporeal Membrane Oxygenation
10/2020 - 05/2016
2Laparotomy
01/2018 - 12/2009
2Length of Stay
10/2016 - 06/2014
2Renal Replacement Therapy (Therapies, Renal Replacement)
06/2014 - 12/2013
2Hemofiltration
12/2013 - 12/2009
2Continuous Renal Replacement Therapy
12/2013 - 12/2009
2Oral Administration
06/2011 - 10/2007
2Lasers (Laser)
01/2005 - 04/2004
1Fluid Therapy (Oral Rehydration Therapy)
01/2020
1Deep Sedation
01/2019